CryoLife Selects Clearant, Inc. to Sterilize Implant of its Cryopreserved Orthopaedic Tissues; Leading Tissue Bank Adopts The CLEARANT PROCESS-R- For The First Time.
Linked as:
Extract
CryoLife Selects Clearant, Inc. to Sterilize Implant of its Cryopreserved Orthopaedic Tissues; Leading Tissue Bank Adopts The CLEARANT PROCESS-R- For The First Time.
ATLANTA -- Clearant, Inc., (OTCBB: CLRI) the developer of the CLEARANT PROCESS(R) for pathogen inactivation announced today that CryoLife, Inc. (NYSE: CRY), a biomaterials and biosurgical device company, had completed their first human i...
See the full content of this document
Sponsored links
